Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) EBT Margin (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed EBT Margin for 6 consecutive years, with 38.82% as the latest value for Q4 2025.

  • On a quarterly basis, EBT Margin fell 1173.0% to 38.82% in Q4 2025 year-over-year; TTM through Dec 2025 was 30.96%, a 959.0% increase, with the full-year FY2025 number at 30.96%, up 959.0% from a year prior.
  • EBT Margin was 38.82% for Q4 2025 at PROCEPT BioRobotics, down from 25.7% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 24.73% in Q2 2025 to a low of 181.0% in Q4 2021.
  • A 5-year average of 88.32% and a median of 73.26% in 2023 define the central range for EBT Margin.
  • Biggest YoY gain for EBT Margin was 35832bps in 2021; the steepest drop was -104368bps in 2021.
  • PROCEPT BioRobotics' EBT Margin stood at 181.0% in 2021, then skyrocketed by 42bps to 104.78% in 2022, then skyrocketed by 40bps to 62.93% in 2023, then surged by 57bps to 27.09% in 2024, then tumbled by -43bps to 38.82% in 2025.
  • Per Business Quant, the three most recent readings for PRCT's EBT Margin are 38.82% (Q4 2025), 25.7% (Q3 2025), and 24.73% (Q2 2025).